Sign in
Active, not recruitingNo phase

Development of a Web-based Multicenter Registry on the Use of oXiris Membrane for EBPTs in Critically Ill Patients

Key facts

Who runs it
Careggi Hospital
Where
Italy12 sites in 1 countryChoose a country to see its sites
Trial code
Status
Active, not recruiting
People taking part
270 people, planned
Started
28 Jun 2019
Ended
30 Sept 2025
Type of study
Observational
Treatments tested
  • oXiris
Record updated
12 February 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 3 criteriaShow less

Who can take part

  • critically ill patients in the ICU
  • treatment with oXiris

Who cannot take part

  • age < 18 years

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The use of extracorporeal blood purification therapies (EBPT) is becoming increasingly widespread worldwide in everyday clinical practice, particularly in the critical care setting. Nonetheless, most of the clinical trials aimed at exploring the effect of EBPT on patients' long-term outcomes have failed to demonstrate consistent results regarding 28 day- or hospital- mortality rates. The aim of this observational prospective registry is to evaluate if there is a cluster of critically ill patients that mostly benefits from extracorporeal blood purification therapies with oXiris membrane.

The group in the trial

  • Critically ill patients

    In centres that obtained IRB approval for this prospective study, all critically ill adult patients (\>18yrs) undergoing treatment with oXiris will be prospectively observed.

    Treatment: oXiris

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Development of a Web-based Multicenter Registry on the Use of oXiris Membrane for Extracorporeal Blood Purification Therapies in Critically Ill Patients
Publications
Record updated
12 February 2025